Abstract
Most widely used approach to enhance drug permeation across skin is the use of chemical penetration enhancers that reversibly and transiently compromise skin barrier function. Ideally, penetration enhancers or any pharmaceutical excipients are expected to be pharmacologically inert and devoid of any clinical and/or histopathological side effects. Despite their wide spread use in topical preparations and high interest in transdermal research and generally regarded as safe (GRAS) status, most penetration enhancers are associated with high incidence of dose-dependent side effects ranging from local irritation to systemic reactions upon acute or chronic use. This chapter attempts to summarize and describe the reported toxicological aspects of some of the commonly used skin penetration enhancer classes such as terpenes, fatty acids, fatty alcohols, alcohols, glycols, laurocapram (Azone®), sulfoxides, pyrrolidones, and surfactants.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ahad A, Aqil M, Kohli K et al (2009) Chemical penetration enhancers: a patent review. Expert Opin Ther Pat 19(7):969–988
Amnuaikit C, Ikeuchi I, Ogawara K et al (2005) Skin permeation of propanolol from polymeric film containing terpene enhancers for transdermal use. Int J Pharm 289(1-2):167–178
Barry BW (1991) The LPP theory of permeation. In: Bronaugh RL, Maibach HI (eds) In vitro percutaneous absorption: principles, fundamentals and applications. CRC Press, Boca Raton, pp 165–183
Barry BW, Bennett SJ (1987) Effect of penetration enhancers on the permeation of mannitol, hydrocortisone, and progesterone through human skin. J Pharm Pharmacol 39:535–546
BIBRA WG (1991) Eucalyptol: 8
Boelsma E, Tanojo H, Bodde HE et al (1996) Assessment of the potential irritancy of oleic acid on human skin: evaluation in vitro and in vivo. Toxicol In Vitro 10:729–742
Brown VK, Robinson J, Stevenson DE (1963) A note on the toxicity and solvent properties of dimethyl sulfoxide. J Pharm Pharmacol 15:688–692
Caujolle FME, Caujolle DH, Cross SB et al (1966) Limits of toxic and teratogenic tolerance of dimethyl sulfoxide. Ann N Y Acad Sci 141(1):110–126
CIR (1994) Final report on the safety assessment of propylene glycol and polypropylene glycols. J Am Coll Toxicol 13(6):437–491
De Vincenzi MD, Silano M, De Vicenzi A (2002) Constituents of aromatic plants: eucalyptol. Fitoterapia 73:269–275
Demierre MF, Vachon L, Ho V et al (2003) Phase 1/2 pilot study of methotrexate-laurocpram topical gel for the treatment of patients with early-stage mycosis fungoides. Arch Dermatol 139:624–628
Fang JY, Hung CF, Chiu HC et al (2003a) Efficacy and irritancy of enhancers on the in vitro and in vivo percutaneous absorption of curcumin. J Pharm Pharmacol 55:593–601
Fang JY, Hwang TL, Fang CL et al (2003b) In vitro and in vivo evaluations of the efficacy and safety of skin permeation enhancers using flurbiprofen as a model drug. Int J Pharm 255:153–166
FDA-CVM (2001) Freedom of information summary-original new drug application NADA 141-327 (Longrange). C. f. V. Medicines. FDA-CVM, Washington, DC
Galloway S, Armstrong M, Reuben C et al (1987) Chromosome aberration and sister chromatid exchanges in Chinese hamster ovary cells: Evaluations of 108 chemicals. Environ Molec Mutagen 10(Suppl 10):1–176
Gao S, Singh J (1998) Effect of oleic acid: ethanol and oleic acid: propylene glycol on the in vitro percutaneous absorption of 5-fluoroacil and tamoxifen and the macroscopic barrier property of porcine epidermis. Int J Pharm 165:45–55
Gosselin RE, Hodge HC, Smith RP et al (1976) Clinical toxicology of commercial products. Williams & Wilkins, Baltimore
Grant WM (1986) Toxicology of the eye. Charles C Thomas Publisher, Springfield
Haworth S, Lawlor T, Mortelmans K et al (1983) Salmonella mutagenicity test results for 250 chemicals. Environ Molec Mutagen 5(Suppl 1):3–142
Heard CM, Screen C (2008) Probing the permeation enhancement of mefenamic acid by ethanol across full-thickness skin, heat-separated epidermal membrane and heat-separated dermal membrane. Int J Pharm 349:323–325
Heard CM, Kung D, Thomas CP (2006) Skin penetration enhancement of mefenamic acid by ethanol and 1,8-cineole can be explained by the “pull” effect. Int J Pharm 321:167–170
HSDB (2008) Oleic acid 112-80-1 HSDB number 1240, HSDB Hazardous Substances Data Bank
Jain AK, Thomas NS, Panchagnula R (2002) Transdermal drug delivery of imipramine hydrochloride. I. Effect of terpenes. J Control Release 79(1-3):93–101
Kanikkannan N, Singh M (2002) Skin penetration enhancement effect and skin irritation of saturated fatty alcohols. Int J Pharm 248:219–228
Kligman AM (1965) Topical pharmacology and toxicology of dimethyl sulfoxide. JAMA 193:796–804, 923–928
Kogan A, Garti N (2006) Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci 123–126:369–385
Kramer A, Berning T, Kampf G (2002) Clinical double-blind trial on the dermal tolerance and user acceptability of six alcohol-based hand desinfectants for hygenic hand desinfection. J Hosp Infect 51:114–120
Kristiansen E, Madsen C (1995) Induction of protein droplet (α2μ-globulin) nephropathy in male rats after short-term dosage with 1,8-cineole and l-limonene. Tox Letters 80:147–152
Lachenmeier DW (2008) Safety evaluation of topical applications of ethanol on the skin and inside the oral cavity. J Occup Med Toxicol 3(26)
Liebert MA (1987) Final report on the safety assessment of oleic acid, lauric acid, palmitic acid, myristic acid, and stearic acid. J Am Coll Toxicol 6(3):321–401
Loffler H, Kampf G, Schmermund D et al (2007) How irritant is alcohol? Br J Dermatl 157:74–81
Lopez-Cervantes M, Marquez-Mejia E, Cazares-Delgadillo J et al (2006) Chemical enhancers for the absorption of substances through the skin: Laurocapram and its derivates. Drug Devel Indust Pharm 32:267–286
Luke E (1962) Addiction to mentholated cigarrettes. Lancet 1:110–111
Medi BM, Singh S, Singh J (2006) Assessing efficacy of penetration enhancers. CRC Press Taylor & Francis Group, Boca Raton
Narishetty ST, Panchagnula R (2004a) Transdermal delivery of zidovudine: effect of terpenes and their mechanism of action. J Control Release 95(3):367–379
Narishetty ST, Panchagnula R (2004b) Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation. Biopharm Drug Dispos 25(1):9–20
NTP (1991) 1,8-Cineol. U. NTP, NTP Chemical Repository:1–6
NTP-PAFA (2006) Eucalyptol 470-8-6. PAFA, NTP-NIH:1–3
O’Mullane NM, Joyce P, Kamath SV et al (1982) Adverse CNS effects of menthol-containing olbas oil. Lancet 319(8281):1121
OECD-SIDS (2001) SIDS Initial Assessment Report for 11th SAM. O. SIDS, UNEP Publications:1–86.
OECD-SIDS (2003) SIDS Initial Assessment Report for SIAM 16. O. SIDS. OECD, Paris, pp 1–59
Ogiso T, Iwaki M, Paku T (1995) Effect of various enhancers on transdermal penetration of indomethacin and urea, and relationship between penetration parameters and enhancement factors. J Pharm Sci 84:482–488
Panchagnula R, Salve PS, Thomas NS, Jain AK, Ramarao P (2001) Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int J Pharm 219(1-2):95–105
Santos FA, Rao VSN (2002) Possible role of mast cells in cineole-induced scratching behavoir in mice. Food Chem Toxicol 40:1453–1457
Sintov A, Ze’evi A, Uzan R et al (1999) Influence of pharmaceutical gel vehiclescontaining olein/sodium oleate combinations on hairless mouse skin, a histological evaluation. Eur J Pharm Biopharm 49:299–303
Smith ER, Hadidian Z, Mason MM (1967) The single-and repeated-dose toxicity of dimethyl sulfoxide. Ann N Y Acad Sci 141(1):96–109
Southwell D, Barry BW (1983) Penetration enhancers for human skin: mode of action of 2-pyrrolidone and dimethylformamide on partition and diffusion of model compounds water, n-alcohols, and caffeine. J Invest Dermatol 80:507–514
Stoner GD, Shimkin MB, Kniazeff AJ et al (1973) Test for carcinogenicity of food additives and chemotherapeutic agents by the pulmonary tumour response in strain A mice. Cancer Res 33:3069–3085
Sutton L, Swinehart JM, Cato A et al (2001) A clinical study to determine the efficacy and safety of 1% methotrexate/Azone (MAZ) gel applied topically once daily in patients with psoriasis vulgaris. Int J Dermatol 40:464–467
Touitou E, Godin B, Karl Y et al (2002) Oleic acid, a skin penetration enhancer, affects Langerhans cells and corneocytes. J Controld Release 80:1–7
Turkoglu M, Sakr A (2001) Evaluation of irritation potential of surfactant mixtures. Int J Cos Sci 21:371–382
Wiechers JW, Drenth BF, Jonkman JH et al (1987) Percutaneous absorption and elimination of the penetration enhancer Azone in humans. Pharm Res 4:519–523
Williams AC, Barry BW (2012) Penetration enhancers. Adv Drug Deliv Rev 64(Suppl Dec 2012):128–137
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Narishetty, S.T., Garcia-Tapia, D., Bonnema, K.J. (2015). Toxicological Aspects of Chemical Penetration Enhancers. In: Dragicevic, N., Maibach, H. (eds) Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-47039-8_25
Download citation
DOI: https://doi.org/10.1007/978-3-662-47039-8_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-47038-1
Online ISBN: 978-3-662-47039-8
eBook Packages: MedicineMedicine (R0)